Item 5. Market for Registrant’s Common Equity
ITEM 5.
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
MARKET INFORMATION
On March 31, 2023, our common stock traded on the NASDAQ Global Select Market under the symbol “PLUS.”
On May 1, 2023, there were 215 stockholders of record of our common stock, although there is a much larger number of beneficial owners.
DIVIDEND POLICIES AND RESTRICTIONS
We did not pay any cash dividends on our common stock during the fiscal years ended March 31, 2023, and 2022. Holders of our common stock are entitled to dividends if and when declared by our Board of
Directors (“Board”), out of funds legally available. Generally, we have retained our earnings for use in the business and to repurchase our common stock. We currently intend to retain future earnings to fund ongoing operations, finance
the growth and development of our business and continue to repurchase our common stock. Any future determination concerning the payment of dividends will depend upon our financial condition, results of operations, capital requirements
and any other factors deemed relevant by our Board.
PURCHASES OF OUR COMMON STOCK
The following table provides information regarding our purchases of our common stock during the three months ended March 31, 2023. Please refer to Note 12 , “Stockholders’ Equity” in the Notes to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for additional
information.
Period
Total
number of shares purchased (1)
Average
price paid per share
Total number of
shares purchased
as part of publicly
announced plans or
programs
Maximum number
of shares that may
yet be purchased
under the plans or
programs (2)
January 1, 2023 through January 31, 2023
0
$
-
0
1,000,000
February 1, 2023 through February 28, 2023
0
$
-
0
1,000,000
March 1, 2023 through March 31, 2023
2,500
$
48.65
2,500
997,500
Total
2,500
2,500
(1)
All shares were acquired in open-market purchases.
(2)
The amounts presented in this column are the remaining number of shares that may be repurchased after repurchases during the month. On March 24, 2022, our board of directors authorized the repurchase of up to 1,000,000 shares
of our outstanding common stock, over a 12-month period beginning May 28, 2022. On March 22, 2023, our board of directors authorized the repurchase of up to 1,000,000 shares of our outstanding
common stock, over a 12-month period beginning May 28, 2023.
ITEM 6.
[RESERVED]
25
Table of Contents
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.